LAVRX
Price
$15.88
Change
+$0.16 (+1.02%)
Updated
Jul 25 closing price
Net Assets
2.04B
VIVIX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

LAVRX vs VIVIX

Header iconLAVRX vs VIVIX Comparison
Open Charts LAVRX vs VIVIXBanner chart's image
Lord Abbett Fundamental Equity R3
Price$15.88
Change+$0.16 (+1.02%)
VolumeN/A
Net Assets2.04B
Vanguard Value Index I
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
LAVRX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAVRX vs. VIVIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVRX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 195B vs. LAVRX (2.04B). VIVIX pays higher dividends than LAVRX: VIVIX (2.19) vs LAVRX (0.58). LAVRX was incepted earlier than VIVIX: LAVRX (18 years) vs VIVIX (27 years). LAVRX (1.20) is less costly to investors than VIVIX (0.04). LAVRX is a more actively managed with annual turnover of: 39.00 vs. VIVIX (9.00). LAVRX has a lower initial minimum investment than VIVIX: LAVRX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 9.75 vs. LAVRX (8.58). VIVIX return over 5 years is better than : 74.87 vs. LAVRX (56.39).
LAVRXVIVIXLAVRX / VIVIX
Total Expense Ratio1.200.043,000%
Annual Report Gross Expense Ratio1.200.043,000%
Fund Existence18 years27 years-
Gain YTD8.1746.730121%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.04B195B1%
Annual Yield % from dividends0.582.1926%
Returns for 1 year8.589.7588%
Returns for 3 years37.3934.32109%
Returns for 5 years56.3974.8775%
Returns for 10 years26.11116.2622%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCECX34.260.36
+1.06%
Fidelity Advisor Consumer Discret C
LFGTX40.810.33
+0.82%
Lord Abbett Focused Growth R5
HQIFX21.320.04
+0.19%
Hartford Equity Income F
PHPSX19.970.01
+0.05%
ProFunds Pharmaceuticals UltraSector Svc
PKAIX14.16-0.03
-0.21%
PIMCO RAE US Instl